
Eva Piëch
business executiveFemale0.0Global Dominance: 0.00%
Eva Piëch is the executive chairwoman of Elysian Group and a key player in the cannabis sector. She recently underscored the strategic decision to move forward with a two-party merger between Elysian and Helius Therapeutics, highlighting the importance of operational clarity and the potential for rapid integration and innovation within the industry.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Eva Piëch explained that the transition to a two-party merger is a strategically focused decision.
Helius and Elysian to continue merger after Cannabis Clinic withdrawalThe New Zealand Herald – country’s largest newspaper, est. 1863·
New Zealand· 2025-07-23



